Cargando…
Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly
Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbil...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771241/ https://www.ncbi.nlm.nih.gov/pubmed/31588241 http://dx.doi.org/10.7150/thno.33741 |
_version_ | 1783455656939880448 |
---|---|
author | Chu, Kuo-An Wang, Shih-Yao Yeh, Chang-Ching Fu, Tz-Win Fu, Yu-Yi Ko, Tsui-Ling Chiu, Mei-Miao Chen, Tien-Hua Tsai, Pei-Jiun Fu, Yu-Show |
author_facet | Chu, Kuo-An Wang, Shih-Yao Yeh, Chang-Ching Fu, Tz-Win Fu, Yu-Yi Ko, Tsui-Ling Chiu, Mei-Miao Chen, Tien-Hua Tsai, Pei-Jiun Fu, Yu-Show |
author_sort | Chu, Kuo-An |
collection | PubMed |
description | Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbilical mesenchymal stem cells (HUMSCs) not only regulate immune responses but also synthesize and release hyaluronan to improve lung regeneration. This study investigated the feasibility of HUMSC engraftment into rats with bleomycin (BLM)-induced PF to explore HUMSC therapeutic effects/outcomes. Methods: A unique BLM-induced left-lung-dominated PF animal model was established. Rats were transplanted with low-dose (5×10(6)) or high-dose (2.5×10(7)) HUMSCs on Day 21 after BLM injection. Combinations in co-culture of pulmonary macrophages, fibroblasts, HUMSCs treated with BLM and the same conditions on alveolar epithelia versus HUMSCs were evaluated. Results: Rats with high-dose HUMSC engraftment displayed significant recovery, including improved blood oxygen saturation levels and respiratory rates. High-dose HUMSC transplantation reversed alveolar injury, reduced cell infiltration and ameliorated collagen deposition. One month posttransplantation, HUMSCs in the rats' lungs remained viable and secreted cytokines without differentiating into alveolar or vascular epithelial cells. Moreover, HUMSCs decreased epithelial-mesenchymal transition in pulmonary inflammation, enhanced macrophage matrix-metallopeptidase-9 (MMP-9) expression for collagen degradation, and promoted toll-like receptor-4 (TLR-4) expression in the lung for alveolar regeneration. In coculture studies, HUMSCs elevated the MMP-9 level in pulmonary macrophages, released hyaluronan into the medium and stimulated the TLR-4 quantity in the alveolar epithelium. Principal Conclusions: Transplanted HUMSCs exhibit long-term viability in rat lungs and can effectively reverse rat PF. |
format | Online Article Text |
id | pubmed-6771241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-67712412019-10-06 Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly Chu, Kuo-An Wang, Shih-Yao Yeh, Chang-Ching Fu, Tz-Win Fu, Yu-Yi Ko, Tsui-Ling Chiu, Mei-Miao Chen, Tien-Hua Tsai, Pei-Jiun Fu, Yu-Show Theranostics Research Paper Pulmonary fibrosis (PF) is a progressive and irreversible condition with various causes, and no effective treatment has been found to rescue fibrotic lungs. Successful recovery from PF requires inhibiting inflammation, promoting collagen degradation and stimulating alveolar regeneration. Human umbilical mesenchymal stem cells (HUMSCs) not only regulate immune responses but also synthesize and release hyaluronan to improve lung regeneration. This study investigated the feasibility of HUMSC engraftment into rats with bleomycin (BLM)-induced PF to explore HUMSC therapeutic effects/outcomes. Methods: A unique BLM-induced left-lung-dominated PF animal model was established. Rats were transplanted with low-dose (5×10(6)) or high-dose (2.5×10(7)) HUMSCs on Day 21 after BLM injection. Combinations in co-culture of pulmonary macrophages, fibroblasts, HUMSCs treated with BLM and the same conditions on alveolar epithelia versus HUMSCs were evaluated. Results: Rats with high-dose HUMSC engraftment displayed significant recovery, including improved blood oxygen saturation levels and respiratory rates. High-dose HUMSC transplantation reversed alveolar injury, reduced cell infiltration and ameliorated collagen deposition. One month posttransplantation, HUMSCs in the rats' lungs remained viable and secreted cytokines without differentiating into alveolar or vascular epithelial cells. Moreover, HUMSCs decreased epithelial-mesenchymal transition in pulmonary inflammation, enhanced macrophage matrix-metallopeptidase-9 (MMP-9) expression for collagen degradation, and promoted toll-like receptor-4 (TLR-4) expression in the lung for alveolar regeneration. In coculture studies, HUMSCs elevated the MMP-9 level in pulmonary macrophages, released hyaluronan into the medium and stimulated the TLR-4 quantity in the alveolar epithelium. Principal Conclusions: Transplanted HUMSCs exhibit long-term viability in rat lungs and can effectively reverse rat PF. Ivyspring International Publisher 2019-09-17 /pmc/articles/PMC6771241/ /pubmed/31588241 http://dx.doi.org/10.7150/thno.33741 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Chu, Kuo-An Wang, Shih-Yao Yeh, Chang-Ching Fu, Tz-Win Fu, Yu-Yi Ko, Tsui-Ling Chiu, Mei-Miao Chen, Tien-Hua Tsai, Pei-Jiun Fu, Yu-Show Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title | Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title_full | Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title_fullStr | Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title_full_unstemmed | Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title_short | Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly |
title_sort | reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from wharton's jelly |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771241/ https://www.ncbi.nlm.nih.gov/pubmed/31588241 http://dx.doi.org/10.7150/thno.33741 |
work_keys_str_mv | AT chukuoan reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT wangshihyao reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT yehchangching reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT futzwin reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT fuyuyi reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT kotsuiling reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT chiumeimiao reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT chentienhua reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT tsaipeijiun reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly AT fuyushow reversalofbleomycininducedratpulmonaryfibrosisbyaxenograftofhumanumbilicalmesenchymalstemcellsfromwhartonsjelly |